H.R. 8807

H.R. 8807: To authorize appropriations for data collection, surveillance, and research on maternal health outcomes during public health emergencies, and for other purposes.

Introduced Lauren Underwood (D) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 8807 is a bill that aims to provide funding for the collection of data, surveillance, and research focused on maternal health outcomes during public health emergencies. This legislation seeks to improve understanding and response to maternal health issues that may arise in times of crisis, ensuring better health outcomes for mothers and their children.

Positive Media Summary

Media coverage has highlighted the importance of addressing maternal health, especially in the context of public health emergencies like pandemics. Supporters of H.R. 8807 argue that the bill represents a proactive step towards improving maternal care and ensuring that health systems are better prepared to support mothers during crises.

Negative Media Summary

Critics of H.R. 8807 have raised concerns about the potential for bureaucratic inefficiencies in data collection and the allocation of funds. Some media outlets have questioned whether the bill adequately addresses the root causes of maternal health disparities, suggesting that it may not lead to substantial improvements in outcomes without accompanying reforms.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

While there are no direct industry overlaps between the sponsor's top donor industries and the subject matter of H.R. 8807, there is notable lobbying activity in the area of maternal health outcomes. For instance, VERDEGO AERO, which has contributed $200,000 through lobbying efforts, may have interests that could intersect with public health funding, even if indirectly. Additionally, the presence of multiple undisclosed contributions from firms like ADNEURIS THERAPEUTICS, INC. and ALUCHEM INC. raises questions about transparency in the influence of these entities on health-related legislation. Voters should be aware that while direct conflicts are not evident, the substantial lobbying amounts suggest potential influence that could shape the outcomes of this bill.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
VERDEGO AERO THE JACKSON GROUP, LLC $200,000
PELION VENTURE PARTNERS THE JACKSON GROUP, LLC $38,000
REFORMING AMERICA'S TAXES EQUITABLY (RATE) SURROUND SOUND STRATEGIES, LLC $30,000
ANELLO PHOTONICS THE JACKSON GROUP, LLC $30,000
SKYFRONT THE JACKSON GROUP, LLC $15,000
47G THE JACKSON GROUP, LLC $15,000
GRAIN CHAIN THE JACKSON GROUP, LLC $5,000
SKYFRONT THE JACKSON GROUP, LLC undisclosed
ADNEURIS THERAPEUTICS, INC. MAD GLOBAL STRATEGY undisclosed
ALUCHEM INC. MAD GLOBAL STRATEGY undisclosed
JOHN BRIAN LEDBETTER MISSIONS JOHN BRIAN LEDBETTER MISSIONS CORPORATION undisclosed
JOHN BRIAN LEDBETTER MISSIONS CORPORATION JOHN BRIAN LEDBETTER MISSIONS CORPORATION undisclosed
GPA MIDSTREAM ASSOCIATION SHUMAKER ADVISORS, LLC undisclosed
WESTLANDS WATER DISTRICT DENNIS CARDOZA CONSULTING SERVICES undisclosed
INDUSTRIOUS GROUP INC. THORN RUN PARTNERS undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Lauren Underwood, ranked by total contributions.

Health Professionals $80,000,000
Individuals: $80,000,000 PACs: $0
Retired $25,000,000
Individuals: $25,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us